CLARIANT LOSES FAITH IN PHARMA

A A

After failing to reverse falling sales at its Pharmaceutical Fine Chemicals (PFC) division, Clariant has decided to sell the unit to private equity firm Towerbrook for around SFr110m (⁈70m).
In-PharmaTechnologist.com